CF PHARMTECH: The Hong Kong public offering was subscribed 6,697.80 times, with a net fundraising of approximately HKD 525 million from the global offering
I'm PortAI, I can summarize articles.
CF PHARMTECH announced its global offering of approximately 41.198 million shares, with 10% allocated for the Hong Kong public offering and 90% for the international offering. The final offer price is HKD 14.75 per share, raising approximately HKD 525 million in net proceeds from the global offering. The Hong Kong public offering was 6,697.80 times oversubscribed, while the international offering was 12.74 times oversubscribed, and trading is expected to commence on the Hong Kong Stock Exchange on October 8, 2025
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments